Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 47, 2023 - Issue 6
91
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 227-236 | Received 22 Sep 2023, Accepted 26 Dec 2023, Published online: 08 Jan 2024

References

  • Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573. doi: 10.1056/NEJMra1510865.
  • Makani J, Cox SE, Soka D, et al. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLOS One. 2011;6(2):e14699. doi: 10.1371/journal.pone.0014699.
  • Narain JP. Health of tribal populations in India: how long can we afford to neglect? Indian J Med Res. 2019;149(3):313–316. doi: 10.4103/ijmr.IJMR_2079_18.
  • Government of India. National Health Mission Guidelines on Hemoglobinopathies in India. Prevention and control of hemoglobinopathies in India-Thalassemias, sickle disease and other variant hemoglobins. New Delhi: Ministry of Health and Family Welfare, Government of India; 2016. Available from: https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/ Guidelines_on_Hemoglobinopathies_in%20India.pdf
  • Government of India. National Sickle Cell Anaemia Elimination Mission in Shahdol, Madhya Pradesh; 2023. Available from: https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1936690
  • Geethakumari K, Kusuma YS, Babu BV. Beyond the screening: the need for health systems intervention for prevention and management of sickle cell disease among tribal population of India. Int J Health Plann Manage. 2021;36(2):236–243. doi: 10.1002/hpm.3081.
  • Sridevi P, Sharma Y, Balakrishna SL, et al. Sickle cell disease treatment and management in India: a systematic review of interventional studies. Trans R Soc Trop Med Hyg. 2022;116(12):1101–1111. doi: 10.1093/trstmh/trac095.
  • Sheshadri V, Shabeer P, Santhirapala V, et al. Mortality in sickle cell disease: a population-based study in an aboriginal community in the Gudalur Valley, Nilgiris, Tamil Nadu, India. Pediatr Blood Cancer. 2021;68(3):e28875. doi: 10.1002/pbc.28875.
  • Government of India DRAFT policy for prevention and control of hemoglobinopathies – thalassemia, sickle cell disease and variant haemoglobins in India. New Delhi: Ministry of Health & Family Welfare, Government of India; 2018. Available from: https://www.nhp.gov.in/NHPfiles/1.pdf
  • Raman V, Seshadri T, Joice SV, et al. Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action. BMJ Glob Health. 2021;6(2):e004322. doi: 10.1136/bmjgh-2020-004322.
  • Thaker P, Colah RB, Patel J, et al. Newborn screening for sickle cell disease among tribal populations in the states of Gujarat and Madhya Pradesh in India: evaluation and outcome over 6 years. Front Med. 2021;8:731884. doi: 10.3389/fmed.2021.731884.
  • Bhattacharya S, Heidler P, Varshney S. Incorporating neglected non-communicable diseases into the National Health Program—a review. Front Public Health. 2022;10:1093170. doi: 10.3389/fpubh.2022.1093170.
  • Saprii L, Richards E, Kokho P, et al. Community health workers in rural India: analysing the opportunities and challenges Accredited Social Health Activists (ASHAs) face in realising their multiple roles. Hum Resour Health. 2015;13(1):95. doi: 10.1186/s12960-015-0094-3.
  • Seth A, Tomar S, Singh K, et al. Differential effects of community health worker visits across social and economic groups in Uttar Pradesh, India: a link between social inequities and health disparities. Int J Equity Health. 2017;16(1):46. doi: 10.1186/s12939-017-0538-6.
  • Babu BV, Sridevi P, Surti SB, et al. Improving the capacity of health system and community for sickle cell disease screening and management among tribal population in India: protocol of an intervention study. Curr Health Sci J. 2020;46(3):270–279. doi: 10.12865/CHSJ.46.03.08.
  • Babu BV, Sharma Y, Sridevi P, et al. Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India. J Med Screen. 2023;30(1):28–35. doi: 10.1177/09691413221123131.
  • Lwanga SK, Lemeshow S. Sample size estimation in health studies. A practical manual. Geneva, Switzerland: World Health Organization; 1991.
  • Babu BV, Sridevi P, Surti S, et al. Inadequate community knowledge about sickle cell disease among the Indian tribal population: a formative assessment in a multicentric intervention study. Trans R Soc Trop Med Hyg. 2021;115(12):1434–1444. doi: 10.1093/trstmh/trab075.
  • Babu BV, Sridevi P, Surti SB, et al. Peripheral health workers’ knowledge and experience related to sickle cell disease: an in-depth interview study in six tribal-dominated districts of India. J Community Genet. 2022;13(3):329–338. doi: 10.1007/s12687-022-00578-z.
  • Babu BV, Sridevi P, Surti SB, et al. Sickle cell disease-related knowledge and perceptions of traditional healers in tribal communities in India: implications on sickle cell disease programme. J Community Genet. 2022;13(6):597–603. doi: 10.1007/s12687-022-00614-y.
  • Babu BV, Sharma Y, Surti SB, et al. Indian sickle cell disease registry for surveillance and patient management: development and implementation. Int J Health Plann Manage. 2023;38(5):1483–1494. doi: 10.1002/hpm.3674.
  • Rahimy MC, Gangbo A, Ahouignan G, et al. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood. 2003;102(3):834–838. doi: 10.1182/blood-2002-05-1453.
  • Kanter J, Kruse-Jarres R. Management of sickle cell disease from childhood through adulthood. Blood Rev. 2013;27(6):279–287. doi: 10.1016/j.blre.2013.09.001.
  • Adams-Graves P, Bronte-Jordan L. Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to care, social issues, and adherence. Expert Rev Hematol. 2016;9(6):541–552. doi: 10.1080/17474086.2016.1180242.
  • Martin BM, Thaniel LN, Speller-Brown BJ, et al. Comprehensive infant clinic for sickle cell disease: outcomes and parental perspective. J Pediatr Health Care. 2018;32(5):485–489. doi: 10.1016/j.pedhc.2018.04.018.
  • de Montalembert M, Tshilolo L, Allali S. Sickle cell disease: a comprehensive program of care from birth. Hematology Am Soc Hematol Educ Program. 2019;2019(1):490–495. doi: 10.1182/hematology.2019000053.
  • Rao VR. Variation of HbS frequency in Indian population: role of P. falciparum and other factors. Indian J Hum Genet. 1998;4(1):23–31.
  • Hsu LL, Green NS, Donnell Ivy E, et al. Community health workers as support for sickle cell care. Am J Prev Med. 2016;51(1 Suppl. 1):S87–S98. doi: 10.1016/j.amepre.2016.01.016.
  • Buser JM, Bakari A, Moyer CA. Feasibility of establishing a network of community health workers to support care of people with sickle cell disease in Kumasi, Ghana. J Community Genet. 2021;12(1):155–161. doi: 10.1007/s12687-020-00501-4.
  • Pack-Mabien A, Haynes JJr. A primary care provider’s guide to preventive and acute care management of adults and children with sickle cell disease. J Am Acad Nurse Pract. 2009;21(5):250–257. doi: 10.1111/j.1745-7599.2009.00401.x.
  • Humphreys JV. The management of sickle cell disease in a primary care setting. J Family Med Prim Care. 2012;1(1):56–58. doi: 10.4103/2249-4863.94454.
  • Brousse V, Makani J, Rees DC. Management of sickle cell disease in the community. BMJ. 2014;348(11):g1765. doi: 10.1136/bmj.g1765.
  • Mainous AG3rd, Carek PJ, Lynch K, et al. Effectiveness of clinical decision support based intervention in the improvement of care for adult sickle cell disease patients in primary care. J Am Board Fam Med. 2018;31(5):812–816. doi: 10.3122/jabfm.2018.05.180106.
  • Hehre RJ. Managing patients with sickle cell disease in primary care. JAAPA. 2020;33(10):21–28. doi: 10.1097/01.JAA.0000697232.25913.b1.
  • Streetly A. Screening infants for sickle cell disease in sub-Saharan Africa: starting the journey to a sustainable model in primary care. Lancet Haematol. 2020;7(7):e503–e504. doi: 10.1016/S2352-3026(20)30180-0.
  • Ibemere SO, Tanabe P, Bonnabeau E, et al. Awareness and use of the sickle cell disease toolbox by primary care providers in North Carolina. J Prim Care Community Health. 2021;12:21501327211049050. doi: 10.1177/21501327211049050.
  • Batina SA, Kambale PK, Sabiti MP, et al. Barriers to health care for sickle cell disease patients in the Democratic Republic of Congo. Afr J Health Issues. 2017;1(1):2.
  • Yusuf HR, Lloyd-Puryear MA, Grant AM, et al. Sickle cell disease: the need for a public health agenda. Am J Prev Med. 2011;41(6 Suppl. 4):S376–S383. doi: 10.1016/j.amepre.2011.09.007.
  • Day LL, Murray E, Treadwell MJ, et al. Teaching about genetics and sickle cell disease in fifth grade. J Natl Med Assoc. 2015;107(1):4–10. doi: 10.1016/S0027-9684(15)30003-1.
  • Tanabe P, Porter J, Creary M, et al. A qualitative analysis of best self management practices: sickle cell disease. J Natl Med Assoc. 2010;102(11):1033–1041. doi: 10.1016/s0027-9684(15)30730-6.
  • Asnani MR, Bhatt K, Younger N, et al. Risky behaviours of Jamaican adolescents with sickle cell disease. Hematology. 2014;19(7):373–379. doi: 10.1179/1607845413Y.0000000136.
  • Burlew AK, Evans R, Oler C. The impact of a child with sickle cell disease on family dynamics. Ann N Y Acad Sci. 1989;565(1):161–171. doi: 10.1111/j.1749-6632.1989.tb24163.x.
  • Kaslow NJ, Collins MH, Rashid FL, et al. The efficacy of a pilot family psychoeducational intervention for pediatric sickle cell disease (SCD). Fam Syst Health. 2000;18(4):381–404. doi: 10.1037/h0091863.
  • Gomes LM, de Andrade Barbosa TL, Vieira ED, et al. Community healthcare workers’ perception of an educational intervention in the care of patients with sickle cell disease in Brazil. Mediterr J Hematol Infect Dis. 2015;7(1):e2015031. doi: 10.4084/MJHID.2015.031.
  • Yacoub MI, Zaiton HI, Abdelghani FA, et al. Effectiveness of an educational program on nurses’ knowledge and practice in the management of acute painful crises in sickle cell disease. J Contin Educ Nurs. 2019;50(2):87–95. doi: 10.3928/00220124-20190115-08.
  • Nimgaonkar V, Krishnamurti L, Prabhakar H, et al. Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India. Pediatr Blood Cancer. 2014;61(4):702–705. doi: 10.1002/pbc.24723.
  • Desai G, Dave KK, Banerjee S, et al. Initial outcomes of a comprehensive care model for sickle cell disease among a tribal population in rural western India. Int J Community Med Public Health. 2016;3(5):1282–1287. doi: 10.18203/2394-6040.ijcmph20161399.
  • Dave K, Chinnakali P, Thekkur P, et al. Attrition from care and clinical outcomes in a cohort of sickle cell disease patients in a tribal area of Western India. Trop Med Infect Dis. 2019;4(4):125. doi: 10.3390/tropicalmed4040125.
  • Institute for Quality and Efficiency in Health Care (IQWiG). Newborn screening for sickle cell disease (SCD): IQWiG Reports – Commission No. S18-01. Cologne (Germany): Institute for Quality and Efficiency in Health Care (IQWiG); 2019.
  • Quinn CT. Sickle cell disease in childhood: from newborn screening through transition to adult medical care. Pediatr Clin North Am. 2013;60(6):1363–1381. doi: 10.1016/j.pcl.2013.09.006.
  • Kulozik AE, Kar BC, Serjeant GR, et al. The molecular basis of alpha thalassemia in India. Its interaction with the sickle cell gene. Blood. 1988;71(2):467–472. doi: 10.1182/blood.V71.2.467.467.
  • Colah RB, Mukherjee MB, Martin S, et al. Sickle cell disease in tribal populations in India. Indian J Med Res. 2015;141(5):509–515. doi: 10.4103/0971-5916.159492.
  • Government of India. National Sickle Cell Anaemia Elimination Mission; 2023 [cited 2023 Nov 15]. Available from: https://sickle.nhm.gov.in/home/user_manual
  • Nardo-Marino A, Brousse V, Rees D. Emerging therapies in sickle cell disease. Br J Haematol. 2020;190(2):149–172. doi: 10.1111/bjh.16504.
  • Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomised trial. N Engl J Med. 1986;314(25):1593–1599. doi: 10.1056/NEJM198606193142501.
  • Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44(11):1428–1433. doi: 10.1086/516781.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.